Rose Michael J, Mascharak Pradip K
Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA.
Curr Opin Chem Biol. 2008 Apr;12(2):238-44. doi: 10.1016/j.cbpa.2008.02.009.
In addition to its beneficial roles in blood pressure regulation, immune response, neurotransmission, and redox balance, nitric oxide (NO) can induce cellular apoptosis at relatively high concentrations. Since photoactive metal nitrosyls can deliver NO under the control of light, they are uniquely suited as NO drugs in photodynamic therapy (PDT) to destroy cancer cells. Stable and photoactive metal nitrosyls can first be placed in close proximity of a malignant site and then triggered via pulses of light to deliver high flux of NO. During the past few years, a number of such metal-based 'NO carriers' have been synthesized and tuned for rapid release of NO upon exposure to UV or visible light. Using various chromophore conjugation strategies, attempts are now being made to photosensitize the M-NO bond to infrared light. Progress has also been made in incorporating metal nitrosyls into biocompatible matrices for site-specific delivery of NO to tumors. A combination of light and NO could offer a viable treatment modality for cancer.
除了在血压调节、免疫反应、神经传递和氧化还原平衡中发挥有益作用外,一氧化氮(NO)在相对较高浓度时可诱导细胞凋亡。由于光活性金属亚硝酰基可以在光的控制下释放NO,它们在光动力疗法(PDT)中作为NO药物来破坏癌细胞具有独特的优势。稳定且光活性的金属亚硝酰基可以首先放置在恶性部位附近,然后通过光脉冲触发以释放高通量的NO。在过去几年中,已经合成了许多这种基于金属的“NO载体”,并对其进行了调整,使其在暴露于紫外线或可见光时能快速释放NO。利用各种发色团共轭策略,目前正在尝试使M-NO键对红外光产生光敏作用。在将金属亚硝酰基纳入生物相容性基质以实现NO向肿瘤的定点递送方面也取得了进展。光和NO的联合应用可能为癌症提供一种可行的治疗方式。